Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar technlogic (< 20) Submitted: 7/2/2011 1:08:54 AM : Outperform Start Price: $1.87 ALXA Score: -79.43

Ascending Triangle

Featured Broker Partners


Advertisement